Blog

  • Honda CD 70, CG 125, and Pridor New Installment Plans after Price Increase – Pakistan Observer

    Honda CD 70, CG 125, and Pridor New Installment Plans after Price Increase – Pakistan Observer

    1. Honda CD 70, CG 125, and Pridor New Installment Plans after Price Increase  Pakistan Observer
    2. Atlas Honda revises motorcycle prices after budgetary levies  Profit by Pakistan Today
    3. United Motorcycles Prices Increased  Pakwheels
    4. Atlas Honda updates bike prices amid new taxes  Mettis Global
    5. Atlas Honda hikes bike prices in Pakistan following new tax imposition  Business Recorder

    Continue Reading

  • ESA Observes Interstellar Comet 3I/ATLAS – astrobiology.com

    1. ESA Observes Interstellar Comet 3I/ATLAS  astrobiology.com
    2. Rare find: interstellar visitor seen blazing through our Solar System  Nature
    3. NASA Discovers Interstellar Comet Moving Through Solar System  NASA Science (.gov)
    4. The new interstellar object A11pl3Z, now 3I/ATLAS: online observation – 3 July 2025  The Virtual Telescope Project 2.0
    5. A new ‘interstellar visitor’ has entered the solar system. Astronomers aren’t sure what it is.  Live Science

    Continue Reading

  • Hüberli/Kernen and Anouk/Zoé take Switzerland to the semis – Volleyball World

    1. Hüberli/Kernen and Anouk/Zoé take Switzerland to the semis  Volleyball World
    2. Anouk and Zoé set up Swiss duel in the Round of 12 in Gstaad  Volleyball World
    3. Swiss Open Gstaad: Successful start for two Swiss women’s duos | blue News  blue News
    4. Beach volleyball tournament in Gstaad: Swiss women’s duos hope to make their debut in the final | blue News  blue News

    Continue Reading

  • 1 Top Cryptocurrency to Buy Before It Soars 471%, According to Wall Street Analyst Geoff Kendrick

    1 Top Cryptocurrency to Buy Before It Soars 471%, According to Wall Street Analyst Geoff Kendrick

    • Standard Chartered analyst Geoff Kendrick is one of the most frequent publishers of crypto research on Wall Street.

    • He covers the largest cryptocurrencies like Bitcoin, all the way to smaller cryptocurrencies as well.

    • One cryptocurrency that Kendrick covers has soared this year, and he sees much more gains ahead.

    • 10 stocks we like better than XRP ›

    There aren’t too many Wall Street analysts publishing price predictions on cryptocurrencies. That’s because digital currencies are much more difficult to value than traditional stocks. They don’t generate cash flow or earnings, nor do they return capital to shareholders; therefore, the traditional valuation methods used by Wall Street analysts don’t apply.

    One strategist who frequently issues crypto price predictions is Geoff Kendrick, the global head of digital asset research at the British bank Standard Chartered. Kendrick is a Wall Street veteran, with 20 years covering global currencies prior to the crypto beat. He has been bullish on Bitcoin, the world’s largest cryptocurrency, but also on other cryptocurrencies, one of which he thinks could soar 471% over the next few years.

    XRP (CRYPTO: XRP) has long been one of the largest cryptocurrencies in the world, and was actually one of the earliest, created in 2012. Investors have been excited about its cross-border payments potential. XRP’s network was among the first that could process many transactions per second, although several competitors have popped up since then.

    Kendrick’s call on XRP, which he made earlier this year, involved three big factors. The first was on the regulatory side and has to do with the Securities and Exchange Commission (SEC).

    In 2020, the SEC sued Ripple, the company behind XRP; one of its co-founders, and its current CEO Brad Garlinghouse, alleging the three parties sold XRP as an unregistered security in 2013. The legal battle carried on for four years, with Ripple seemingly winning the case at times, but the SEC appealing parts of the court decision it disagreed with.

    The lawsuit attracted unwanted attention for XRP because it could have set a precedent over how much jurisdiction the SEC had over certain cryptocurrencies. So, most crypto investors were watching it, which may have created negative sentiment for XRP.

    Image source: Getty Images.

    But once President Donald Trump won the election last November and ushered in a pro-crypto administration, leadership at the SEC changed, and the agency eventually dropped or settled several high-profile crypto cases, including with Ripple. That led the price of XRP to surge and cleared the way for other catalysts like spot-XRP exchange-traded funds (ETFs).

    Continue Reading

  • Benjamin Thomas: “It’s a legendary jersey”

    Benjamin Thomas: “It’s a legendary jersey”

    “I’m really happy, because that’s what we had decided in the team briefing. I was free to break away. Once I took the first point, I needed a second to secure the polka dot jersey, and it all came down to Mont Cassel.

    It’s a place I know well because we often ride there during the 4 Jours de Dunkerque. And yet I attacked too early, Matteo came back and we had to sprint. On the cobbles, you always sprint sitting down, but when I threw the bike forward, I lost my balance, my front wheel came off and we fell. I didn’t even know if I had crossed the line first!

    It was entirely my fault, so I went to apologise to him and luckily he’s fine. I’m a bit sore and I’ll be aching for two or three days, but nothing too serious.

    It’s my first climber’s jersey, in any race, so I’m really happy. And of course, the one in the Tour is legendary. We’ll see tomorrow if it’s worth trying to break away, but I’d like to keep it.”

    05/07/2025 – Tour de France 2025 – Étape 1 – Lille Métropole / Lille Métropole (184,9 km) – Benjamin THOMAS (COFIDIS) © A.S.O./Charly Lopez


    Continue Reading

  • Eyes on Venus: Earth’s Weather Satellites Unlock Secrets of the Hottest Planet – SciTechDaily

    1. Eyes on Venus: Earth’s Weather Satellites Unlock Secrets of the Hottest Planet  SciTechDaily
    2. Weather Satellites Can Even Study the Weather Over on Venus  Universe Today
    3. Serendipitous satellite snapshots show Venus’s weather evolving over nearly a decade  Phys.org
    4. Tasked to watch Earth, Japanese satellite makes big discovery on Venus  India Today
    5. Watch: Venus’s weather changing over almost a decade  NewsBytes

    Continue Reading

  • Round 8 Post Sprint Race Press Conference

    Round 8 Post Sprint Race Press Conference

    FIA Formula 2: Hello and welcome to Silverstone for the press conference of our top three finishers in today’s FIA Formula 2 Sprint Race. In third place we have Roman Stanek from Invicta Racing, in second is Sebastián Montoya from PREMA Racing and your race winner for the first time in FIA Formula 2 is Leonardo Fornaroli also from Invicta Racing, Leo not only your first win in F2 but by my calculations your first win in 1491 days, how are the emotions right now?

    Leonardo Fornaroli: I am very happy, very satisfied with the race. It wasn’t a very good start and Kush past me. Then I said no please I have to regain that P1. We fought quite a bit going to T7 and then luckily managed to repass him. There was no Safety Car so it was like a Qualifying race. I knew what to do to have a nice gap to keep P2 behind before the big DRS zone, otherwise they would pass me. It was fun, very happy about the tyre management and everything because I was able to drive in good conditions at the end to be able to fight with Sebastián. It was quite close, we were pushing like crazy. Very satisfied with today, it’s a Sprint Race of course but still P1 feels good.

    FIA Formula 2: You said you’d been trying to get that win and how much you wanted it, I know you say it is just a Sprint Race but you have consistently been at the front the last few years, were you confident once you got into the lead that you could convert?

    Fornaroli: Yes today I was quite confident that I could take it. The last round I started on Pole a few times and I couldn’t get the win; I really wanted that P1 and finally I took it. I am very satisfied.

    FIA Formula 2: Were there any nerves in the car on those closing laps, you mentioned that Sebastián was putting you under pressure in those final few laps?

    Fornaroli: Well there was also a bit of pressure at the start because Kush was quite close. I knew that the pace was good. We had changed quite a lot of things, compared to yesterday, it is also nice to bounce back from a disappointing quali. I saw the pace was good today, so I am also quite happy about that, happy that the adjustments we made worked. Speaking of the race, mid-race I saw Kush dropping back and five, six laps to go Seb overtook him and he was looking strong, so I said okay it’s time to push. Luckily I was in good conditions with the tyres. I was able to remain in front of him. Happy about today.

    FIA Formula 2: Congratulations on the win, Seb second place for you, your third podium of the season, how strong did you feel out there?

    Sebastian Montoya: Very! I was very fast, very competitive. Last week we had a very competitive race car but due to the contact in the Feature Race I kind of dropped back quite a way with damage and had to drive through. I was hoping to have that speed advantage again this weekend and I guess I got it. I was really happy from the first lap of FP we have been very competitive. It was a really fun race.

    FIA Formula 2: You put in one quick lap on the penultimate lap of the race to cut that gap to about a second to Leo, were you saving a bit to push late at the end?

    Montoya: Yeah it was quite difficult to overtake, especially with Kush sometimes having DRS it was hard to know exactly when I was going to be able to overtake. But I knew I had the pace advantage so I managed the best I could. I saw I was catching Leo and then I realised that we were doing the same lap time so one lap I decided to drop back a bit and take care of my tyres before pushing again. The moment I closed the gap he started pushing more and more as well. At that point I think, I spent a lot of laps behind Kush trying to fight with him, so my tyres were a bit off. I was trying to catch at the end but as I said the wind was hectic and the dirty air is quite big, Leo had strong pace, so it was hard to overtake. But I’m happy with P2.

    FIA Formula 2: This result means four top five finishes in a row for you now, do you feel like you are really starting to hit your stride in Formula 2?

    Montoya: I think I have been hitting my stride since Jeddah honestly, even in Australia I was really competitive I just made a mistake in Qualifying but still finished P6 in the Sprint. Bahrain was difficult for us but then we bounced back in Jeddah. We had some unfortunate luck and then we came back to Europe, and we have been very competitive the whole time. I am very grateful for the team and the people I have around me. We are doing a mega job and working really hard to keep improving and that’s our goal. Just take it race by race, day by day and just get better every time we go out on track.

    FIA Formula 2: Thanks well done today, Roman onto you now another third place for you, your second in three races but how tough was that one?

    Roman Stanek: Well, it wasn’t so tough, physically a little bit because Silverstone is a tough track. It was quite fun I have to say. I managed to get a good start, I actually tried to overtake Seb but I wasn’t able to do it. Then I had quite strong pace, it was quite difficult to overtake Kush so Seb and I stuck behind him for a while. Then Seb overtook him and then I managed to overtake him at two laps to go I think. He defended a lot but I managed to open the DRS and stay close and stick it around the outside of T15 which felt quite nice. Really enjoyed that race, it’s a shame that we started further back, maybe if we could start further up, but it’s a Sprint Race so good that we start further up tomorrow.

    FIA Formula 2: Just talk us through that move with Kush late in the race there, were you concerned that the stewards were going to take a look at it at any point? They did clear you of any wrong doing there.

    Stanek: No because I knew that I was ahead of him at the apex of the corner, so I just kept it flat on the exit of the corner. I don’t even remember if I ran wide, most likely yes. But he was defending the whole race a lot, so I felt relief to overtake him finally. Even if I was going to get a five second penalty, I don’t even know how much in front I finished, maybe three or four seconds, it wouldn’t have been enough but no I enjoyed that race.

    FIA Formula 2: With Leo’s win and your podium, it is a big day for the team as well, how well are you guys all working together at the moment?

    Stanek; Since the beginning of the season I have to say that the team is amazing. They have been very welcoming and supportive. Everyone actually, I enjoy it so much and I learn, although it is my third season in F2, every day you keep learning knew and knew information. With these guys I have learnt a lot so far. I am just very grateful that I can represent Czech Republic in this sport and be racing at a high level of motorsport.

    FIA Formula 2: Well done Roman, congratulations everyone.

    Continue Reading

  • Study finds key cause of heart disease

    Study finds key cause of heart disease

    For decades, doctors have tackled heart disease by focusing on well-known risk factors—high blood pressure, high cholesterol, and diabetes. Medications like aspirin and statins have helped millions, yet heart disease remains the leading cause of death in the United States. Alarmingly, many people still suffer heart attacks even when these traditional risk factors are well-managed.

    Now, researchers at the University of Michigan have identified a new piece of the puzzle that could explain why.

    Their study highlights a protein called suPAR (soluble urokinase plasminogen activator receptor), produced by the immune system. Unlike cholesterol or blood pressure, suPAR appears to directly cause atherosclerosis—the buildup of plaque in the arteries that can lead to heart attacks and strokes.

    Atherosclerosis affects more than a billion people worldwide. It occurs when fatty deposits accumulate along artery walls, restricting blood flow and increasing the risk of serious cardiovascular events.

    SuPAR is produced in the bone marrow and acts like an inflammation “thermostat” in the body. Scientists already knew that people with elevated suPAR levels had a higher risk of heart disease, but this study is the first to show that suPAR may be a direct cause of the disease.

    The research began with an analysis of over 5,000 people without known heart disease. Those with higher suPAR levels were significantly more likely to develop atherosclerosis, regardless of their cholesterol or blood pressure levels.

    To find out why some people have higher suPAR levels, the team examined genetic data from 24,000 individuals. They identified a specific genetic variant in the PLAUR gene, which produces suPAR. People with this variant had both higher suPAR levels and a greater risk of developing atherosclerosis.

    Using a method called Mendelian randomization—which leverages genetic data to explore cause-and-effect relationships—the researchers confirmed their findings in more than 500,000 participants from the UK Biobank and two additional datasets. The link between the PLAUR variant, elevated suPAR, and atherosclerosis was consistently strong.

    To further validate their discovery, the team conducted experiments on mice. Those given high levels of suPAR developed significantly more plaque in their aortas—the main arteries leading from the heart—than mice with normal levels. This provided compelling evidence that suPAR actively contributes to artery damage.

    What makes this discovery particularly significant is that suPAR is not affected by current heart disease treatments. Statins, for example, do not lower suPAR levels. This opens the door to a completely new treatment approach, targeting a mechanism not addressed by existing drugs.

    Led by Dr. Salim Hayek, the researchers are now working on therapies aimed at safely reducing suPAR levels, with the goal of preventing or slowing the progression of heart disease.

    This breakthrough may also shed light on the close link between heart and kidney disease. Prior studies have associated suPAR with kidney damage, and in the U.S., about 1 in 7 people have kidney disease—two-thirds of whom also have heart disease. In fact, more than 40% of heart disease patients show signs of kidney dysfunction. If suPAR contributes to both, targeting it could offer dual benefits.

    Published in the Journal of Clinical Investigation, this study may redefine how doctors understand and treat heart disease—offering new hope to millions of people who continue to face it, despite following all the right steps.


    Continue Reading

  • Starts With a Bang podcast #119 – The CMB

    Starts With a Bang podcast #119 – The CMB




    Starts With a Bang podcast #119 – The CMB – Big Think



















    Skip to content

    Starts With A Bang —

    The relic signal that first proved the Big Bang has been known and analyzed for 60 years. Join us at the frontiers of modern cosmology!

    This image shows the Large Aperture Telescope’s colossal, 6-meter primary and secondary mirrors at the Simons Observatory in February of 2025. The telescope has already seen first light, and will soon begin delivering new CMB science as never before.

    Credit: M. Devlin/Simons Observatory

    Key Takeaways


    • Many different alternative ideas about our cosmic origins abounded until the mid-1960s, when the discovery of the CMB, identified as the Big Bang’s leftover glow, was first identified.

    • In all that time since, observations have confirmed and strengthened this picture, while subsequent CMB analysis has revealed even more information about our primeval Universe.

    • Many think that the story of the CMB ended with Planck, but the past 10 years have shown that so much more remains to be discovered. Come join us on the frontiers in this fascinating CMB-focused podcast episode!

    Sign up for the Starts With a Bang newsletter

    Travel the universe with Dr. Ethan Siegel as he answers the biggest questions of all.

    Perhaps the strongest evidence we’ve ever acquired in support of the Big Bang has been the discovery of the leftover radiation from its early, hot, dense state: today’s cosmic microwave background, or CMB. While there were many competing ideas for our cosmic origins, only the Big Bang predicted a uniform, omnidirectional bath of blackbody radiation: exactly what the CMB is.

    But it turns out the CMB encodes much more information than just our cosmic origins; it allows us to map the very early Universe from when it was just 380,000 years old, and gives us vital information about what has happened to light from that time over its 13.8 billion year journey to our eyes. It encodes information about our cosmic expansion history, about dark matter and dark energy, about intervening galaxy clusters, and about the material here in our own galaxy, along with much more. It is, arguably, the richest source of information from any one single observable in our entire Universe.

    Here to guide us through what CMB scientists are working on here in 2025, including what we’ve learned and what we’re still trying to find out, I’m so pleased to welcome Dr. Patricio Gallardo to the show. We’ve got more than an hour and a half of quality science to go through, and by the end, I bet you’ll be more excited about the upcoming Simons Observatory, designed to measure the CMB to higher precision than ever before, than you knew you should be. Enjoy!

    Sign up for the Starts With a Bang newsletter

    Travel the universe with Dr. Ethan Siegel as he answers the biggest questions of all.

    The CMB has long been considered the Big Bang’s “smoking gun” evidence. But after what JWST saw, might it come from early galaxies instead?

    Originally, the abundance of bright, early galaxies shocked astronomers. After 3 years of JWST, we now know what’s really going on.

    For over 50 years, it’s been the scientifically accepted theory describing the origin of the Universe. It’s time we all learned its truths.

    If you want to understand the Universe, cosmologically, you just can’t do it without the Friedmann equation. With it, the cosmos is yours.

    The hunt for extraterrestrial life begins with planets like Earth. But our inhabited Earth once looked very different than Earth does today.

    The CMB has long been considered the Big Bang’s “smoking gun” evidence. But after what JWST saw, might it come from early galaxies instead?

    Subscribe

    Get surprising and impactful stories delivered to your inbox every week.

    Get Big Think for Your Business.
    Enable transformation and drive culture at your company with lessons from the biggest thinkers in the world.

    Learn More →

    © Copyright 2007-2025 & BIG THINK, BIG THINK PLUS, SMARTER FASTER trademarks owned by Freethink Media, Inc. All rights reserved.

    {notificationOpen=false}, 2000);” x-data=”{notificationOpen: false, notificationTimeout: undefined, notificationText: ”}”>

    Continue Reading

  • Anti-ageing or life-threatening? What experts say after Shefali Jariwala’s death

    Anti-ageing or life-threatening? What experts say after Shefali Jariwala’s death

    Lifestyle Desk

    05 July 2025, 10:00 PM IST

    Experts warn of the rising popularity of these largely unstudied products, citing potential harmful side effects, especially from intravenous injections bypassing natural bodily protections

    The sudden demise of actress Shefali Jariwala has sparked fresh debate over the safety and regulation of anti-ageing medicines in India.

    The 42-year-old, who shot to fame with the 2002 music video Kaanta Laga, passed away on June 27 in Mumbai, reportedly due to cardiac arrest.

    However, emerging reports suggest she had been self-administering a combination of anti-ageing injections while fasting, raising serious concerns about the unregulated use of such treatments.

    What are anti-ageing medicines and are they regulated?

    Experts have warned that while anti-ageing treatments are becoming increasingly popular, many products in the market are not backed by proper scientific studies and remain largely unregulated.

    “Anti-ageing medicine is becoming very popular but it’s mostly unregulated. Many of these products are sold without proper scientific studies to prove they work. Some may even have harmful side effects, especially if taken for long periods,” said former AIIMS Director, Dr Randeep Guleria, in a statement.

    Is ‘anti-ageing’ even a scientific term?

    Medical professionals also stress that the term ‘anti-ageing’ itself is misleading.

    “Anti-ageing is not a scientific term. Such products do not reverse or stop natural ageing. Skin whitening is possible with certain medications, but that is not the same as anti-ageing,” said Dr Rajeev Jayadevan, Convener, Research Cell, Kerala State IMA.

    What was Shefali Jariwala using?

    Reports from the ongoing police investigation suggest that Shefali had been using skin-whitening and anti-ageing injections, particularly glutathione and Vitamin C, for around eight years. Importantly, she was not under active medical supervision during this period, aside from an initial consultation.

    Dr Jayadevan explaining the dangers of this approach said, “When a medication is given as an IV injection, it bypasses the natural protection offered by gut absorption and liver metabolism. Thus, the drug may reach very high concentrations in blood and tissues.”

    He further warned, “IV medications must be carefully regulated and contamination avoided at all costs.”

    Are these injections safe?

    According to Dr Jayadevan, there have been international incidents highlighting the risks.

    “There are reports from Australia and Philippines about contamination of IV glutathione vials with toxins and also serious side effects of such products,” he added.

    Why are these products still popular?

    India is witnessing a cosmetic boom, fuelled by rising aspirations and social media influence. According to the latest ISAPS Global Survey, India ranks among the top 10 countries globally for aesthetic and cosmetic procedures, behind only the US, Brazil, and Japan.

    However, this rapid rise is not without consequence.

    Should these medicines be banned?

    Experts believe regulation is the need of the hour and that banning harmful products should not be ruled out.

    “There is definitely a need to regulate such medicines. If there’s no proper evidence about their safety or usefulness, and they are found to be harmful, then yes — they should be banned,” said Dr Guleria. “The same applies to other medicines, like muscle-building drugs that are often misused.”

    Subscribe to our Newsletter

    Get Latest Mathrubhumi Updates in English

    Follow

    Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.

    Continue Reading